Loading asset research
Benitec Biopharma Inc. Common Stock
BNTCNasdaq · USD · StocksQuote as of · Exchange session not verified$11.36
+2.90%
Today
Next earnings call
The next call has not been scheduled by the current earnings provider.
EPS vs. consensus estimate
- Actual
- Estimate
Q3 24Q1 25Q3 25Q 25FY 25Q1 26Q2 26Q3 26
Revenue vs. consensus estimate
- Actual
- Estimate
Q1 24Q2 24Q3 24Q4 24Q1 25Q3 25FY 252026-09
EPS surprise history
Q 25Q3 26
Beat or met consensus in 50% of the last 4 reported quarters.
Previous reports
Values are converted from USD into your selected display currency. Actuals are drawn from SEC filings (XBRL) and Yahoo statements; estimates and surprises from Nasdaq where available.
| Fiscal period | Report date | Normalized EPS | EPS surprise | Revenue | Rev. surprise | Actions |
|---|---|---|---|---|---|---|
| — | Sep 14, 2026 | — / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q3 2026 | May 14, 2026 | -$0.24 / (-$0.27 est.) | +11.11% | 0 (unit unavailable) / (— est.) | — | Source |
| Q2 2026 | Feb 12, 2026 | -$0.26 / (-$0.23 est.) | -13.04% | 0 (unit unavailable) / (— est.) | — | Source |
| Q1 2026 | Nov 14, 2025 | -$0.22 / (-$0.35 est.) | +37.14% | 0 (unit unavailable) / (— est.) | — | Source |
| FY 2025 | Sep 22, 2025 | -$0.21 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q 2025 | Sep 22, 2025 | -$0.42 / (-$0.28 est.) | -50.00% | 0 (unit unavailable) / (— est.) | — | Source |
| Q3 2025 | May 14, 2025 | -$0.38 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q1 2025 | Nov 14, 2024 | -$0.18 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q4 2024 | Sep 26, 2024 | 4.7 (unit unavailable) / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q3 2024 | May 13, 2024 | -$0.23 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q2 2024 | Feb 13, 2024 | -$2.64 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q1 2024 | Nov 13, 2023 | -$3.05 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q4 2023 | Sep 21, 2023 | -0.13 (unit unavailable) / (— est.) | — | $7K / (— est.) | — | Source |
| Q3 2023 | May 15, 2023 | -$2.67 / (— est.) | — | $54K / (— est.) | — | Source |
| Q1 2023 | Nov 10, 2022 | -$7.98 / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q4 2022 | Sep 2, 2022 | -36.27 (unit unavailable) / (— est.) | — | $0.00 / (— est.) | — | Source |
| Q2 2023 | Feb 14, 2022 | -$0.59 / (— est.) | — | $25K / (— est.) | — | Source |
| Q4 2021 | Sep 20, 2021 | — / (— est.) | — | $2K / (— est.) | — | Source |
| Q3 2021 | May 12, 2021 | — / (— est.) | — | 1,000 (unit unavailable) / (— est.) | — | — |
| Q2 2021 | Feb 9, 2021 | — / (— est.) | — | 1,000 (unit unavailable) / (— est.) | — | — |
| Q1 2021 | Nov 13, 2020 | — / (— est.) | — | 55,000 (unit unavailable) / (— est.) | — | — |
| Q4 2020 | Sep 23, 2020 | — / (— est.) | — | -$36K / (— est.) | — | Source |
Regulatory filings
Company reports filed with the SEC.